
09/10/2025
💙 A Heartfelt Goodbye + A Warm Welcome 💙
We are sad to share that our CFO, Ken Titlebaum, will be stepping down on October 1, 2025. Ken has been a tremendous leader over the last three years — guiding ALPCO through the acquisition of GeneProof, helping double NuvinkaDx revenue, and strengthening our financial foundation.
Ken will remain as a part-time consultant through the end of the year, and we are deeply grateful for everything he has done.
At the same time, we’re excited to welcome Francesco Fragasso as our new CFO! Francesco brings decades of experience in healthcare and diagnostics finance, and we can’t wait to see where his leadership will take us.
Please join us in both thanking Ken and welcoming Francesco to the ALPCO team. 💙
https://ow.ly/Nf4F50WUvQl